Picard Medical, Inc. (PMI) Stock Analysis & Investment Frameworks
Picard Medical, Inc. (PMI) stock analysis on Invetso. Review Picard Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Picard Medical, Inc. Company Overview
- Exchange: New York Stock Exchange Arca
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Picard Medical, Inc. Key Financial Metrics
- Market Cap: $1.31B
- Revenue: $4.94M
- ROE: -931.09%
- ROIC: -584.43%
- Dividend Yield: N/A
About Picard Medical, Inc.
Picard Medical, Inc., through its associated companies, is dedicated to the entire process of medical device commercialization, from initial design and manufacturing to production, distribution, marketing, and sales. A key product in its portfolio is the SynCardia TAH, a sophisticated total artificial heart specifically engineered to supplant a failing human heart in individuals afflicted with advanced cardiac disease. The firm's market presence extends across the United States, Europe, and other international regions. Established in 2021, Picard Medical maintains its primary operations in Tucson, Arizona, functioning as a direct subsidiary of Hunniwell Picard I, Llc.
Picard Medical, Inc. Investment Frameworks
Invetso analyzes Picard Medical, Inc. (PMI) across the following frameworks:
- Picard Medical, Inc. 10Y Growth Potential
- Picard Medical, Inc. Scenario Analysis
- Picard Medical, Inc. Risks & Opportunities
- Picard Medical, Inc. Economic Moat
- Picard Medical, Inc. Business Model
- Picard Medical, Inc. Management
- Picard Medical, Inc. SWOT Analysis
- Picard Medical, Inc. Porter's 5 Forces
- Picard Medical, Inc. PESTLE Analysis
- Picard Medical, Inc. ESG Analysis